Evaluation of Polygenic Determinants of Non-Alcoholic Fatty Liver Disease (NAFLD) By a Candidate Genes Resequencing Strategy

被引:60
|
作者
Di Costanzo, Alessia [1 ]
Belardinilli, Francesca [2 ]
Bailetti, Diego [3 ]
Sponziello, Marialuisa [1 ]
D'Erasmo, Laura [1 ]
Polimeni, Licia [1 ]
Baratta, Francesco [1 ,4 ]
Pastori, Daniele [1 ,4 ]
Ceci, Fabrizio [5 ]
Montali, Anna [1 ]
Girelli, Gabriella [6 ]
De Masi, Bruna [6 ]
Angeloni, Antonio [2 ]
Giannini, Giuseppe [2 ]
Del Ben, Maria [1 ]
Angelico, Francesco [7 ]
Arca, Marcello [1 ]
机构
[1] Sapienza Univ, Dept Internal Med & Med Specialties, Rome, Italy
[2] Sapienza Univ, Dept Mol Med, Rome, Italy
[3] Sapienza Univ, Dept Expt Med, Rome, Italy
[4] Sapienza Univ, Dept Anat Histol Forens Med & Ortoped Sci, Rome, Italy
[5] Sapienza Univ, Dept Cellular Biotechnol & Hematol, Rome, Italy
[6] Sapienza Univ, Immunohematol & Transfus Med Unit, Rome, Italy
[7] Sapienza Univ, Dept Publ Hlth & Infect Dis, Rome, Italy
来源
SCIENTIFIC REPORTS | 2018年 / 8卷
关键词
GENOME-WIDE ASSOCIATION; SUPERFAMILY MEMBER 2; CONFERS SUSCEPTIBILITY; VARIANT; RISK; PNPLA3; SEVERITY; MBOAT7; TM6SF2; STEATOHEPATITIS;
D O I
10.1038/s41598-018-21939-0
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
NAFLD is a polygenic condition but the individual and cumulative contribution of identified genes remains to be established. To get additional insight into the genetic architecture of NAFLD, GWAS-identified GCKR, PPP1R3B, NCAN, LYPLAL1 and TM6SF2 genes were resequenced by next generation sequencing in a cohort of 218 NAFLD subjects and 227 controls, where PNPLA3 rs738409 and MBOAT7 rs641738 genotypes were also obtained. A total of 168 sequence variants were detected and 47 were annotated as functional. When all functional variants within each gene were considered, only those in TM6SF2 accumulate in NAFLD subjects compared to controls (P = 0.04). Among individual variants, rs1260326 in GCKR and rs641738 in MBOAT7 (recessive), rs58542926 in TM6SF2 and rs738409 in PNPLA3 (dominant) emerged as associated to NAFLD, with PNPLA3 rs738409 being the strongest predictor (OR 3.12, 95% CI, 1.8-5.5, P < 0.001). A 4-SNPs weighted genetic risk score value > 0.28 was associated with a 3-fold increased risk of NAFLD. Interestingly, rs61756425 in PPP1R3B and rs641738 in MBOAT7 genes were predictors of NAFLD severity. Overall, TM6SF2, GCKR, PNPLA3 and MBOAT7 were confirmed to be associated with NAFLD and a score based on these genes was highly predictive of this condition. In addition, PPP1R3B and MBOAT7 might influence NAFLD severity.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Adipokines and Endotoxemia Correlate with Hepatic Steatosis in Non-Alcoholic Fatty Liver Disease (NAFLD)
    Nier, Anika
    Huber, Yvonne
    Labenz, Christian
    Michel, Maurice
    Bergheim, Ina
    Schattenberg, Joern M.
    NUTRIENTS, 2020, 12 (03)
  • [22] Validating candidate biomarkers for different stages of non-alcoholic fatty liver disease
    Al-Qarni, Reem
    Iqbal, Muhammad
    Al-Otaibi, Maram
    Al-Saif, Faisal
    Alfadda, Assim A.
    Alkhalidi, Hisham
    Bamehriz, Fahad
    Hassanain, Mazen
    MEDICINE, 2020, 99 (36) : E21463
  • [23] Genetics of Non-Alcoholic Fatty Liver and Cardiovascular Disease: Implications for Therapy?
    Chandrasekharan, Karthik
    Alazawi, William
    FRONTIERS IN PHARMACOLOGY, 2020, 10
  • [24] Identifying Candidate Flavonoids for Non-Alcoholic Fatty Liver Disease by Network-Based Strategy
    Lee, Won-Yung
    Lee, Choong-Yeol
    Lee, Jin-Seok
    Kim, Chang-Eop
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [25] Bioinformatics-Driven Identification and Examination of Candidate Genes for Non-Alcoholic Fatty Liver Disease
    Banasik, Karina
    Justesen, Johanne M.
    Hornbak, Malene
    Krarup, Nikolaj T.
    Gjesing, Anette P.
    Sandholt, Camilla H.
    Jensen, Thomas S.
    Grarup, Niels
    Andersson, Asa
    Jorgensen, Torben
    Witte, Daniel R.
    Sandbaek, Annelli
    Lauritzen, Torsten
    Thorens, Bernard
    Brunak, Soren
    Sorensen, Thorkild I. A.
    Pedersen, Oluf
    Hansen, Torben
    PLOS ONE, 2011, 6 (01):
  • [26] Non-alcoholic fatty liver disease and type 2 diabetes mellitus
    Par Alajos
    Wittmann Istvan
    Par Gabriella
    ORVOSI HETILAP, 2022, 163 (21) : 815 - 825
  • [27] Beyond the liver in patients with non-alcoholic fatty liver disease (NAFLD)-cause for concern?
    Armstrong, Matthew J.
    Haydon, Geoffrey
    Syn, Wing-Kin
    HEPATOBILIARY SURGERY AND NUTRITION, 2018, 7 (02) : 138 - 142
  • [28] Non-invasive assessment of fibrosis in non-alcoholic fatty liver disease (NAFLD)
    Vizzutti, Francesco
    Arena, Umberto
    Nobili, Valerio
    Tarquini, Roberto
    Trappoliere, Marco
    Laffi, Giacomo
    Marra, Fabio
    Pinzani, Massimo
    ANNALS OF HEPATOLOGY, 2009, 8 (02) : 89 - 94
  • [29] Predictors of Liver Fat and Stiffness in Non-Alcoholic Fatty Liver Disease (NAFLD) - an 11-Year Prospective Study
    Lallukka, Susanna
    Sadevirta, Sanja
    Kallio, Markus T.
    Luukkonen, Panu K.
    Zhou, You
    Hakkarainen, Antti
    Lundbom, Nina
    Orho-Melanders, Marju
    Yki-Jarvinen, Hannele
    SCIENTIFIC REPORTS, 2017, 7
  • [30] Plasmatic higher levels of homocysteine in Non-alcoholic fatty liver disease (NAFLD)
    Rampche de Carvalho, Sylene Coutinho
    Cartaxo Muniz, Maria Tereza
    Vieira Siqueira, Maria Deozete
    Forte Siqueira, Erika Rabelo
    Gomes, Adriana Vieira
    Silva, Karina Alves
    Luma Bezerra, Lais Carvalho
    D'Almeida, Vania
    Marques Souza de Oliveira, Claudia Pinto
    Beltrao Pereira, Leila Maria M.
    NUTRITION JOURNAL, 2013, 12